These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2637856)

  • 1. [Medicamental reduction of salivation with a plaster containing scopolamine in restorative prosthetics].
    Negendank B; Merten HA; Hönig JF
    Dtsch Zahnarztl Z; 1989 Sep; 44(9):722-3. PubMed ID: 2637856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of salivary flow with Scopoderm TTS.
    Talmi YP; Finkelstein Y; Zohar Y; Laurian N
    Ann Otol Rhinol Laryngol; 1988; 97(2 Pt 1):128-30. PubMed ID: 3355042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal scopolamine use for post-rhytidectomy sialocele.
    Lapid O; Kreiger Y; Sagi A
    Aesthetic Plast Surg; 2004; 28(1):24-8. PubMed ID: 15116278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative in-flight study of a scopolamine-containing membrane plaster versus dimenhydrinate under defined acceleration conditions].
    Offenloch K; Zahner G; Dietlein G; Franz I
    Arzneimittelforschung; 1986 Sep; 36(9):1401-6. PubMed ID: 3539128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.
    Nachum Z; Shupak A; Gordon CR
    Clin Pharmacokinet; 2006; 45(6):543-66. PubMed ID: 16719539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of salivary flow with transdermal scopolamine: a four-year experience.
    Talmi YP; Finkelstein Y; Zohar Y
    Otolaryngol Head Neck Surg; 1990 Oct; 103(4):615-8. PubMed ID: 2123321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transdermal therapeutic system of scopolamine (TTS-S) in the prevention of sea sickness and its mechanism of action].
    Wang E
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Oct; 25(5):299-302, 319. PubMed ID: 2076342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal scopolamine to reduce salivation and possibly aspiration after stroke.
    Rønning OM; Stavem K
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):328-9. PubMed ID: 18755415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Scopoderm in palliative care.
    Spiller JA; Fallon M
    Hosp Med; 2000 Nov; 61(11):782-4. PubMed ID: 11198747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of the cardiovascular and antisialogogue effects among glycopyrrolate, scopolamine and atropine in man.
    Hsu JC; Wong CS; Chen TS; Chang CL
    Ma Zui Xue Za Zhi; 1986 Mar; 24(1):39-44. PubMed ID: 3784806
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects and side effects of transdermal scopolamine for premedication in general anesthesia in elderly patients].
    Tolksdorf W; Baumann S; Heine C; Hettenbach A
    Anasth Intensivther Notfallmed; 1986 Dec; 21(6):301-6. PubMed ID: 3544938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transdermal scopolamine or droperidol in the prevention of postoperative nausea and vomiting in cholecystectomy patients].
    Schuh R; Tolksdorf W; Hucke H
    Anasth Intensivther Notfallmed; 1987 Dec; 22(6):261-6. PubMed ID: 3326423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New alternatives in dental premedication--antisecretory and sedative effects of scopolamine solutions].
    Markkanen YJ
    Suom Hammaslaakarilehti; 1986 Jun; 33(11):670-4. PubMed ID: 3462859
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transdermal scopolamine (TTS-scopolamine) for the prevention of postoperative nausea and vomiting].
    Tolksdorf W; Meisel R; Müller P; Bender HJ
    Anaesthesist; 1985 Dec; 34(12):656-62. PubMed ID: 4096357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy].
    Becker G; Goossens H; Seemann K; Souchon F; Weitz T
    Dtsch Med Wochenschr; 1984 Dec; 109(49):1881-5. PubMed ID: 6499689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Control of drooling with scopolamine ointment for severely disabled].
    Yokoyama R; Kawara H; Ishii H
    No To Hattatsu; 1994 Jul; 26(4):357-8. PubMed ID: 8074901
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral scopolamine hydrobromide solution as an antisialagogic agent in dentistry.
    Markkanen YJ; Pihlajamäki K
    Oral Surg Oral Med Oral Pathol; 1987 Apr; 63(4):417-20. PubMed ID: 3472139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of kinetosis in children. Transdermal therapy with scopolamine].
    Müller M; Besch W; Steilner D
    Fortschr Med; 1987 Feb; 105(4):82, 86-7. PubMed ID: 3557264
    [No Abstract]   [Full Text] [Related]  

  • 19. Salivation in mice as an index of adrenergic activity. II. The effects of atropines and ganglionic blocking agents on adrenergic salivation and temperature responses in mice.
    Koppanyi T; Maling HM
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):333-43. PubMed ID: 4403619
    [No Abstract]   [Full Text] [Related]  

  • 20. Delirium from transdermal scopolamine in an elderly woman.
    Rozzini R; Inzoli M; Trabucchï M
    JAMA; 1988 Jul 22-29; 260(4):478. PubMed ID: 3385907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.